期刊文献+

加替沙星软胶囊剂处方的研究

Study on the formulation of gatiflocaxin soft gelatin capsules
下载PDF
导出
摘要 目的研究加替沙星软胶囊内容物的最佳处方。方法以药物溶出度为考察指标,用紫外分光光度法测定加替沙星软胶囊溶出度,并对其内容物处方进行比较筛选。结果以m(PEG400)∶m(甘油)∶m(水)=20∶1∶1的混悬液为内容物处方,所制备的加替沙星软胶囊溶出迅速完全,稳定性好。结论加替沙星软胶囊最优基质处方为m(PEG400)∶m∶(甘油)∶m(水)=20∶1∶1。 Objective To choose the optimum formulation of gatiflocaxin soft gelatin capsules. Method UV method was established to determine the dissolution of gatifloxacin from the soft gelatin capsules.With the dissolution as the index, several different formulations were studied and compared in the experiment.Results The gatifloxacin soft gelatin capsules,which were prepared with the mixture of PEG400, glycerin and water(m:m:m = 20:1:1), dissolved quickly and adequately. Conclusion The appropriate formulation is the mixture of PEG 400,glycerin and water(m:m:m = 20:1:1).
出处 《中国药剂学杂志(网络版)》 2005年第2期37-40,共4页 Chinese Journal of Pharmaceutics:Online Edition
关键词 药剂学 软胶囊 处方 溶出度 加替沙星 pharmaceutics soft gelatin capsules formulation dissolution gatifloxacin
  • 相关文献

参考文献7

二级参考文献21

  • 1周银龙.软胶丸的生物利用度和崩解[J].中国药学杂志,1993,28(7):427-430. 被引量:13
  • 2罗青波.我国软胶囊制剂的现状与出路[J].上海医药情报研究,1995(1):13-14. 被引量:5
  • 3吴明福.脉通胶丸质量改进[J].医药工业,1985,16:7-10. 被引量:2
  • 4[3]Curtis JJ. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients filiation. Am J Kidney Dis, 1999, 34(5): 869 被引量:1
  • 5[4]Min DI. Bioavailability and patient acceptance of cyclosporine soft geltin capsules in renal allograft recipients. Ann Pharmacother, 1992,26(2): 175 被引量:1
  • 6[5]Kovarik JM.Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation. Pharmacotherapy, 1993,13(6): 613 被引量:1
  • 7[6]Sadler BM.Safety and pharmacokinetics of amprenavir (141W94),a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults. Antimicrob Agents Chemother, 1999,43(7): 1686 被引量:1
  • 8[7]Hong SS. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J Control Release, 1998, 1251(2~3): 185 被引量:1
  • 9[8]Takahashi M. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. Ⅵ.Preparation and evaluation of ibuprofen soft gelatin capsule. Chem Pharm Bull (Tokyo),1995,43(8): 1398 被引量:1
  • 10[9]Takahashi M. Studies on dissolution tests for soft gelatin capsules. Ⅳ. Dissolution test of nifedipine soft gelatin capsule containing water soluble vehicles by the rotating dialysis cell method. Chem Pharm Bull (Tokyo),1994,42(2): 333 被引量:1

共引文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部